Frontiers in Oncology | Breast Cancer

Original Research

Published on 28 Oct 2022

Determining prognostic factors and optimal surgical intervention for early-onset triple-negative breast cancer

in Breast Cancer

Yi-Zi Zheng
Yan Liu
Zhen-Han Deng
Guo-Wen Liu
Ni Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.910765

2,780 views
7 citations

Review

Published on 28 Oct 2022

Circadian disruption and cancer- and treatment-related symptoms

in Breast Cancer

Ali Amidi
Lisa M. Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1009064

9,127 views
31 citations

Original Research

Published on 27 Oct 2022

Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study

in Breast Cancer

Yuting Sang
Xujie Zhou
Weiru Chi
Jiajian Chen
Benlong Yang
Shuang Hao
Xiaoyan Huang
Guangyu Liu
Zhimin Shao
Jiong Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.984587

3,481 views
8 citations

Original Research

Published on 27 Oct 2022

Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials

in Breast Cancer

Ming Xie
Yan Zhong
Yide Yang
Fang Shen
Yue Nie

Frontiers in Oncology

doi 10.3389/fonc.2022.1039320

4,117 views
12 citations

Original Research

Published on 26 Oct 2022

Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis

in Breast Cancer

Jae Sik Kim
Jin Ho Kim
Ji Hyun Chang
Do Wook Kim
Kyung Hwan Shin

Frontiers in Oncology

doi 10.3389/fonc.2022.1026043

4,282 views
12 citations

Original Research

Published on 26 Oct 2022

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice

in Breast Cancer

Giuseppe Buono
Grazia Arpino
Lucia Del Mastro
Alessandra Fabi
Daniele Generali
Fabio Puglisi
Alberto Zambelli
Saverio Cinieri
Francesco Nuzzo
Vincenzo Di Lauro

Frontiers in Oncology

doi 10.3389/fonc.2022.1032166

4,110 views
5 citations

Review

Published on 25 Oct 2022

Breast cancer liver metastasis: Pathogenesis and clinical implications

in Breast Cancer

Cuiwei Liu
Srivarshini C. Mohan
Jielin Wei
Ekihiro Seki
Manran Liu
Reva Basho
Armando E. Giuliano
Yanxia Zhao
Xiaojiang Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.1043771

15,060 views
16 citations

Clinical Trial

Published on 24 Oct 2022

Strategies in activating lymphatic system to promote lymph flow on lymphedema symptoms in breast cancer survivors: A randomized controlled trial

in Breast Cancer

Xinwen Du
Yuan Li
Lan Fu
Huaying Chen
Xiaoxia Zhang
Yuping Shui
Aihua Zhang
Xianqiong Feng
Mei Rosemary Fu

Frontiers in Oncology

doi 10.3389/fonc.2022.1015387

4,177 views
9 citations

Original Research

Published on 21 Oct 2022

A nomogram to identify appropriate candidates for breast-conserving surgery among young women with breast cancer: A large cohort study

in Breast Cancer

Shengyu Pu
Shaoran Song
Heyan Chen
Can Zhou
Huimin Zhang
Ke Wang
Jianjun He
Jian Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1012689

1,990 views
2 citations

Original Research

Published on 21 Oct 2022

Optimization of a method for the clinical detection of serum exosomal miR-940 as a potential biomarker of breast cancer

in Breast Cancer

Zhiyun Gu
Haojie Yin
Haiwei Zhang
Hui Zhang
Xiaoyu Liu
Xiaohua Zeng
Xiaodong Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.956167

3,274 views
11 citations

Original Research

Published on 21 Oct 2022

Relationship between telomere length and the prognosis of breast cancer based on estrogen receptor status: A Mendelian randomization study

in Breast Cancer

Yilun Li
Li Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1024772

5,403 views
11 citations

Original Research

Published on 20 Oct 2022

ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer

in Breast Cancer

Yilun Li
Xiaomei Liao
Li Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.955719

2,649 views
5 citations

Original Research

Published on 20 Oct 2022

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience

in Breast Cancer

Sabah Alaklabi
Arya Mariam Roy
Kristopher Attwood
Anthony George
Tracey O’Connor
Amy Early
Ellis G. Levine
Shipra Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2022.1012391

7,538 views
12 citations

Original Research

Published on 20 Oct 2022

A nomogram based on radiomics signature and deep-learning signature for preoperative prediction of axillary lymph node metastasis in breast cancer

in Breast Cancer

Dawei Wang
Yiqi Hu
Chenao Zhan
Qi Zhang
Yiping Wu
Tao Ai

Frontiers in Oncology

doi 10.3389/fonc.2022.940655

4,548 views
24 citations

Original Research

Published on 20 Oct 2022

Human clinical trial using diagnostic ultrasound and microbubbles to enhance neoadjuvant chemotherapy in HER2- negative breast cancer

in Breast Cancer

Biqiang Zhou
Qingshu Lian
Chunchun Jin
Jianghao Lu
Lifeng Xu
Xuehao Gong
Peng Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.992774

3,236 views
13 citations

Original Research

Published on 18 Oct 2022

Health-related quality of life measured by EQ-5D-3L for the spouses of breast cancer patients

in Breast Cancer

Li-Fei Sun
Sheng Huang
Yun-Fen Li
Zhuang-Qing Yang
Xiao-Juan Yang
Jie-Ya Zou
Xiao-Wen Wang
Jian-Yun Nie

Frontiers in Oncology

doi 10.3389/fonc.2022.983704

2,436 views
5 citations